Page last updated: 2024-10-29

ifosfamide and Severe Combined Immunodeficiency

ifosfamide has been researched along with Severe Combined Immunodeficiency in 1 studies

Severe Combined Immunodeficiency: Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goan, SR1
Fichtner, I1
Just, U1
Karawajew, L1
Schultze, W1
Krause, KP1
von Harsdorf, S1
von Schilling, C1
Herrmann, F1

Other Studies

1 other study available for ifosfamide and Severe Combined Immunodeficiency

ArticleYear
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
    Blood, 1995, Jul-01, Volume: 86, Issue:1

    Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone

1995